Market Place
Sourcing Support
DKSH Technology acquires Korean life science firm MDxK
01 Apr 2025 //
PRESS RELEASE
US judge rejects J&J`s $10 billion baby powder settlement
01 Apr 2025 //
REUTERS
AZ`s Imfinzi wins perioperative FDA nod in bladder cancer
01 Apr 2025 //
FIERCE PHARMA
ICON plc Schedules First Quarter 2025 Earnings Conference Call
31 Mar 2025 //
BUSINESSWIRE
Seaport Therapeutics to Join Investor Conferences in April
31 Mar 2025 //
BUSINESSWIRE
Kairos Pharma Ltd. Completes Safety Arm of ENV105 Trial
31 Mar 2025 //
BUSINESSWIRE
KalVista Pharmaceuticals at 24th Annual Needham Healthcare Confer
31 Mar 2025 //
BUSINESSWIRE
Adicet Bio to Join 2025 Canaccord Genuity Oncology Conference
31 Mar 2025 //
BUSINESSWIRE
Tenpoint Therapeutics to Join Investor Conferences in April
31 Mar 2025 //
BUSINESSWIRE
Alpha Cognition Reports Q4 and Full Year 2024 Financials
31 Mar 2025 //
BUSINESSWIRE
USAntibiotics Names Mark Tengler Senior VP of Manufacturing Tech
31 Mar 2025 //
BUSINESSWIRE
Forte Biosciences Updates on Results and Clinical Progress
31 Mar 2025 //
BUSINESSWIRE
Cycle Vita™ adds BAFIERTAM® for Multiple Sclerosis support
31 Mar 2025 //
BUSINESSWIRE
bioAffinity Technologies Reports $9.4M Revenue in 2024
31 Mar 2025 //
BUSINESSWIRE
Lynch Regenerative Medicine Acquires REGRANEX Gel & Exclusive Right
31 Mar 2025 //
BUSINESSWIRE
ACC: Low-Dose Colchicine Reduces Coronary Plaque Progression
31 Mar 2025 //
BUSINESSWIRE
Omeros Corporation Reports 2024 Financial Results
31 Mar 2025 //
BUSINESSWIRE
Circle Pharma to Present at the Upcoming Investor Conferences
31 Mar 2025 //
BUSINESSWIRE
Travere Therapeutics to Present New FILSPARI® Data at NKF Spring
31 Mar 2025 //
BUSINESSWIRE
Geron to Announce Q1 2025 Financial Results on May 7, 2025
31 Mar 2025 //
BUSINESSWIRE
Navidea Biopharmaceuticals extends plan to protect tax assets
31 Mar 2025 //
BUSINESSWIRE
Johnson & Johnson to Defeat Talc Claims in Tort System
31 Mar 2025 //
BUSINESSWIRE
SPARC submits IND application for SBO-154 to USFDA
31 Mar 2025 //
#N/A
USC-licensed startup NeOnc Technologies gets NASDAQ listing
31 Mar 2025 //
#N/A
HRV Global Life Sciences delivers Indian anti-diabetic drugs
31 Mar 2025 //
#N/A
Theravance Biopharma to Join Investor Conference
31 Mar 2025 //
PR NEWSWIRE
Aurora Cannabis Recognized for Gender Diversity by Globe and Mail
31 Mar 2025 //
PR NEWSWIRE
Prime Therapeutics showcases GLP-1 research at AMCP 2025
31 Mar 2025 //
PR NEWSWIRE
Orna Therapeutics Names Joseph Bolen, Ph.D., CEO
31 Mar 2025 //
PR NEWSWIRE
Vanda Phama Announces Submission of an NDA to the FDA for Bysanti
31 Mar 2025 //
PR NEWSWIRE
AbbVie to Host First-Quarter 2025 Earnings Conference Call
31 Mar 2025 //
PR NEWSWIRE
Blueprint Medicines at 24th Annual Needham Healthcare Conf.
31 Mar 2025 //
PR NEWSWIRE
HOPE & NRx Pharma Announce Purchase Agreement with Dura Medical
31 Mar 2025 //
PR NEWSWIRE
Talphera reduces NEPHRO CRRT study size to 70 patients
31 Mar 2025 //
PR NEWSWIRE
Spinogenix Announces Phase 2 US Trial Enrollment for SPG302
31 Mar 2025 //
PR NEWSWIRE
Neurocrine Biosciences Presents Real-World Data on VMAT2 Inhibitors
31 Mar 2025 //
PR NEWSWIRE
Mitsubishi Tanabe Pharma to Share Data at 2025 AD/PD
31 Mar 2025 //
PR NEWSWIRE
Lundbeck expands finding to IV Lu AG09222 in migraine prevention
31 Mar 2025 //
PR NEWSWIRE
Talphera Announces 2024 Financial Results and Corporate Update
31 Mar 2025 //
PR NEWSWIRE
Carisma Therapeutics Provides Corporate Updates
31 Mar 2025 //
PR NEWSWIRE
Hoth Receives USPTO Filing Receipt for HT-001 Patent Application
31 Mar 2025 //
PR NEWSWIRE
Innocan Pharma Reports 2024 Revenue Doubles to US $29.4M
31 Mar 2025 //
PR NEWSWIRE
Genomma Lab First Quarter 2025 Earnings Results Conference Call
31 Mar 2025 //
PR NEWSWIRE
Merck Exercised Option for Global Rights of Abbisko`s Pimicotinib
31 Mar 2025 //
PR NEWSWIRE
Novartis appoints Karen Hale as Chief Legal Officer; Klaus Moosma
31 Mar 2025 //
GLOBENEWSWIRE
Transactions under Novonesis hare buyback program
31 Mar 2025 //
GLOBENEWSWIRE
Venus Concept Announces Q4 and FY 2024 Financial Results
31 Mar 2025 //
GLOBENEWSWIRE
Ocular Therapeutix™ to Attend Two Investor Conferences in April
31 Mar 2025 //
GLOBENEWSWIRE
Cabaletta Bio Reports Q4 and Full Year 2024 Financial Results
31 Mar 2025 //
GLOBENEWSWIRE
Elicio Therapeutics Reports 2024 Financial Results & Updates
31 Mar 2025 //
GLOBENEWSWIRE
BioStem Receives Notice of Allowance for Two U.S. Patents
31 Mar 2025 //
GLOBENEWSWIRE
Gyre Therapeutics gets NMPA approval for Pirfenidone trial
31 Mar 2025 //
GLOBENEWSWIRE
Aclarion updates company positioning after Q1 initiatives
31 Mar 2025 //
GLOBENEWSWIRE
Atavistik Bio Appoints William Sellers, M.D. to Advisory Board
31 Mar 2025 //
GLOBENEWSWIRE
Applied Therapeutics Files Form 12b-25 with SEC
31 Mar 2025 //
GLOBENEWSWIRE
Anteris Technologies: 100 patients treated with DurAVR® THV
31 Mar 2025 //
GLOBENEWSWIRE
Anavex Life Sciences to Present at Needham Healthcare Conference
31 Mar 2025 //
GLOBENEWSWIRE
Maze Therapeutics Reports 2024 Financial Results and Highlights
31 Mar 2025 //
GLOBENEWSWIRE
Vivani Medical Reports Q4 and Full Year 2024 Financial Results
31 Mar 2025 //
GLOBENEWSWIRE
SAB BIO Reports Full Year 2024 Operating and Financial Results
31 Mar 2025 //
GLOBENEWSWIRE
